HIV Testing Strategies in the Perinatal Setting
NCT00503308 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 281
Last updated 2015-05-22
Summary
The purpose of the study is to determine whether an abbreviated pretest/post-test CDC recommended counseling is as equally acceptable to prenatal patients as the standard strategy using prenatal care nurses and medical providers at San Francisco General Hospital \[SFGH\]).
Conditions
- HIV Infections
- Pregnancy Related
Interventions
- PROCEDURE
-
Abbreviated HIV test counseling
abbreviated HIV pre-test counseling
Sponsors & Collaborators
- collaborator INDUSTRY
-
University of California, San Francisco
lead OTHER
Principal Investigators
-
Deborah Cohan, MD · University of California, San Francisco
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 16 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-10-31
- Primary Completion
- 2007-09-30
- Completion
- 2008-02-29
Countries
- United States
Study Locations
More Related Trials
-
A Study of Zidovudine in HIV-Infected Pregnant Women and Their Children
NCT00001106 ·Status: COMPLETED ·Phase: PHASE1
-
Primary HIV Prevention in Pregnant and Lactating Ugandan Women
NCT01882998 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of Antiretroviral Agents in HIV-1 Infected Pregnant Women
NCT00006320 ·Status: COMPLETED ·Phase: PHASE1
-
Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women
NCT01621347 ·Status: COMPLETED
-
The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants
NCT00000960 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy
NCT00017719 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
NCT01618305 ·Status: COMPLETED ·Phase: PHASE4
-
Progesterone Supplementation for HIV-positive Pregnant Women on Anti-Retrovirals
NCT02400021 ·Status: UNKNOWN ·Phase: PHASE2
-
An Integrated Strategy to Support Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence for HIV Prevention in Pregnant and Breastfeeding Women
NCT04330989 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Measurement of Maternal Viral Load at Delivery to Optimise Post-natal Prophylaxis of HIV-exposed Newborns
NCT05017558 ·Status: UNKNOWN
-
Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women
NCT00993031 ·Status: COMPLETED ·Phase: PHASE3
-
Optimizing Prevention and Care for Pregnant and Postpartum Adolescent Girls and Young Women With HIV in Tanzania
NCT06605053 ·Status: RECRUITING ·Phase: NA
-
A Study of HIV Levels During Pregnancy and After Childbirth
NCT00041964 ·Status: COMPLETED
-
A Study of Zidovudine During Labor and Delivery in HIV-Infected Pregnant Women
NCT00000862 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies
NCT00000888 ·Status: COMPLETED ·Phase: PHASE1
-
Viral and Antiretroviral Dynamics in HIV-1 Mother-to-Child Transmission Fluids
NCT03284645 ·Status: COMPLETED
-
Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV
NCT00086359 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication
NCT01865786 ·Status: COMPLETED
-
ART Readiness in HIV-infected Pregnant Women
NCT02459678 ·Status: COMPLETED ·Phase: NA
-
An Intervention to Improve Antenatal Access to CD4 Testing and HAART in Botswana
NCT01836003 ·Status: COMPLETED ·Phase: NA
-
Development of Resistance Mutations in Pregnant HIV-positive (+) Women Following Perinatal Antiretroviral Therapy in Israel
NCT00197366 ·Status: TERMINATED
-
Pre-Exposure Prophylaxis Dosing in Pregnancy to Optimize HIV Prevention (PREP-P)
NCT03834909 ·Status: WITHDRAWN ·Phase: PHASE1
-
Optimizing HIV Virologic Outcomes for Pregnant Women in Uganda
NCT04122144 ·Status: UNKNOWN ·Phase: NA
-
Enhanced Virologic Monitoring for Pregnant and Postpartum Women With HIV
NCT05845619 ·Status: COMPLETED ·Phase: NA
-
Testing Implementation Strategies to Improve Delivery of PrEP for Pregnant and Postpartum Women in Kenya
NCT05482360 ·Status: COMPLETED ·Phase: NA